Girish Meenakshi, Subramaniam Girish
Children's Hospital, Midas Heights, Nagpur, India.
Indian J Pediatr. 2008 May;75(5):521-2. doi: 10.1007/s12098-008-0084-8. Epub 2008 Jun 8.
Kawasaki syndrome is one of the commonest vasculitides in pediatric age group with devastating consequences if not treated early. Intravenous Gammaglobulin leads to rapid amelioration of clinical symptoms and significantly decreases the risk of development of coronary artery aneurysms. Occasionally, Kawasaki disease may be resistant to I/V IgG. We present our experience with one such patient who ultimately respondend to infliximab therapy.
川崎病是儿童期最常见的血管炎之一，如果不及早治疗会产生严重后果。静脉注射丙种球蛋白可使临床症状迅速改善，并显著降低冠状动脉瘤形成的风险。偶尔，川崎病可能对静脉注射免疫球蛋白耐药。我们介绍了我们对一名此类患者的治疗经验，该患者最终对英夫利昔单抗治疗有反应。
